The answer to why medicines work differently in different people is often found in our genes. Genomic Medicine Sweden is now taking a major step towards making pharmacogenetic testing available at all university hospitals. With a national gene panel, more patients...
The government has decided on a national coordination structure for precision health, with the goal that all patients will have equal access to the personalised care of the future. The assignment has been given to the National Board of Health and Welfare, which,...
Genomic Medicine Sweden (GMS) has published the report Collaboration in Precision Medicine since 2017, which summarises recent developments in precision medicine in Sweden. The report shows how national collaboration between healthcare, academia, government agencies,...
FOCU.SE is a new Swedish study in which genetic analysis of tumours is used to match cancer patients with targeted drugs outside of approved indication. The aim is to give more people access to effective treatment, while gathering valuable knowledge for the future. In...
Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a perspective article published in Nature Genetics, researchers highlight how long-read whole genome sequencing, LR-WGS, offers a paradigm shift in...
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
Anpassa samtycke
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
